Fibrinogen is a protein produced by the liver that's essential for blood clotting. It's converted into fibrin, the mesh that stabilizes clots. It also acts as an acute-phase inflammatory marker, rising in response to systemic inflammation.
Elevated fibrinogen contributes to cardiovascular risk through two mechanisms: increased clotting tendency (thrombosis risk) and as a marker of chronic inflammation. It's useful alongside hs-CRP because the two capture different aspects of inflammation and sometimes disagree. A person can have normal CRP but elevated fibrinogen or vice versa.
Optimal Fibrinogen Activity: 200-300 mg/dL.
Typically re-tested every 12 weeks.
Typical adult lab reference ranges sit around 200 to 400 mg/dL. One value is a snapshot of a protein that moves with illness, injury and hormones, so the trend over time usually tells you more than a single reading.
Fibrinogen activity is the measured concentration of fibrinogen in plasma that is actually capable of forming a clot, rather than simply the amount of fibrinogen protein present.
Fibrinogen is coagulation factor I, a large soluble glycoprotein made by the liver and carried in plasma at a higher concentration than any other clotting factor. When a vessel is injured, thrombin cleaves fibrinogen into fibrin monomers. Those monomers polymerise into strands, factor XIII cross-links them, and the resulting mesh traps platelets and red cells into a stable clot. Fibrinogen also acts as the bridge between activated platelets, so it contributes to both the cellular and the protein side of clot formation.
The functional assay most labs use is the Clauss method. Diluted plasma is mixed with a large excess of thrombin, and the time to clot formation is measured. A shorter clotting time means more functional fibrinogen, and the result is read against a calibration curve, which is why the output is a concentration in mg/dL rather than a time in seconds[1].
There is a second way to measure the same protein. An immunologic or antigen assay counts fibrinogen molecules regardless of whether they work. When the activity result is clearly lower than the antigen result, the protein may be present but structurally abnormal, a pattern labs investigate as part of a wider bleeding-disorder workup rather than treating as a finding on its own[2].
Fibrinogen matters because it sits at two crossroads at once, the end point of the clotting cascade and the inflammatory response of the liver.
On the clotting side, fibrinogen is the final substrate every coagulation pathway converges on. In major haemorrhage and severe trauma it is often the first clotting factor to fall to a level where clots stop forming properly, which is why fibrinogen measurement has become central to how bleeding is assessed and managed in acute care[3]. Rapid, accurate fibrinogen testing is an active area of diagnostic development for exactly this reason[1]. Fibrinogen is also one of the handful of measurements used when a clinician works up unexplained bruising or bleeding in general practice[4].
On the inflammatory side, fibrinogen is an acute-phase reactant. Inflammatory signalling tells the liver to produce more of it, so levels climb during infection, after surgery, after injury and in chronic inflammatory states. Higher concentrations also raise plasma viscosity and make red cells stack more readily, which is part of why erythrocyte sedimentation rate tracks fibrinogen so closely.
That second role is where the long-term interest sits. Research has consistently associated higher fibrinogen concentrations with atherothrombotic disease, and work on common variants in the fibrinogen genes has examined how inherited differences in baseline levels relate to that risk[5]. Association is not the same as cause, and no single marker predicts an individual outcome. It is also worth keeping the distinction that biomarker research draws elsewhere in medicine, between a prognostic marker that tracks risk over time and a predictive marker that signals who may respond to a particular treatment, a separation made explicitly in chronic obstructive pulmonary disease research[6]. Fibrinogen is best read as a risk and inflammation signal, not as an instruction.
Most adult labs report a typical reference range of roughly 200 to 400 mg/dL for fibrinogen activity measured by the Clauss method.
| Range type | Value | What it represents |
|---|---|---|
| Standard lab reference range | 200 to 400 mg/dL | The interval typically reported for adults by clinical laboratories |
| FitScript optimal range | 200 to 300 mg/dL | FitScript's optimization target for members |
Fibrinogen runs slightly higher in women than in men and rises with age. In 637 healthy Saudi adults the range for women sat a little higher, and a Chinese study of 297 adults found a higher lower limit after 50.[13][14]
| Sex | Age | Reference range (g/L) |
|---|---|---|
| Men | 17 to 60 | 2.1 to 4.5 |
| Women | 17 to 60 | 2.2 to 4.9 |
| Men and women | 18 to 50 | 1.85 to 3.80 |
| Men and women | 51 to 88 | 2.22 to 3.86 |
The two studies used different populations and analyzers, which is why their ranges differ.[13][14] Neither split fibrinogen by sex and age together. For ages 18 to 50, the second study's table prints an upper limit of 3.80 while its text gives 3.78; the table value is shown here.[14] US labs often report mg/dL, where 1 g/L equals 100 mg/dL. Your own lab's printed range is the one to read your result against.
Reference ranges vary by laboratory, assay calibration, age and sex, so always read your result against the range printed on your own report. FitScript's optimal range is an optimization target used for tracking, not a diagnostic cut-off, and a value outside it is not a diagnosis of anything. No age-banded ranges are published here because none have been supplied, and inventing one would be worse than leaving it out.
Two practical notes. Pregnancy raises fibrinogen substantially above the non-pregnant range as a normal physiological change, so obstetric results are interpreted against pregnancy-specific expectations[7]. And a result sitting just outside a range after a recent infection often looks different a few weeks later.
A high fibrinogen activity result usually means the liver has increased production in response to inflammation, and far less often that something is wrong with clotting itself.
Symptoms people report. Elevated fibrinogen does not produce symptoms of its own. People generally discover it on a panel ordered for another reason. What they may notice are features of whatever is driving it, such as fatigue during a lingering infection, joint stiffness in an inflammatory condition, or nothing at all when the cause is smoking or body composition.
Common causes. Acute infection, recent surgery, trauma or burns, pregnancy and the postpartum period[7], oestrogen-containing medications, cigarette smoking, excess visceral fat and metabolic syndrome, chronic kidney disease, some cancers, and ordinary ageing all push the number up. Inherited variation in the fibrinogen genes also sets part of a person's baseline, which is why two healthy people with identical habits can run different levels[5].
Long-term health impact. Sustained elevation is associated with atherothrombotic disease in population research and with higher plasma viscosity[5]. The clearance side of the system matters too. Impaired breakdown of fibrin within small dermal vessels has long been described in conditions such as atrophie blanche, where vessel occlusion rather than fibrinogen concentration is the problem[8]. The practical reading is that a high value is a prompt to look for a driver, not a verdict.
So the sequence is straightforward. The value shows increased functional fibrinogen. It may reflect an acute-phase response, a lifestyle driver or an inherited baseline. A persistent elevation, especially alongside other raised inflammatory markers, is worth discussing with a clinician, who can decide whether a repeat test after recovery or a wider workup makes sense.
A low fibrinogen activity result means less functional clotting protein is available, either because the liver is making less, because it is being consumed faster than it is replaced, or because the protein present does not work normally.
Symptoms people report. Mild reductions are usually silent. As levels fall further, people may describe easy bruising, nosebleeds, prolonged oozing from small cuts, bleeding after dental work, heavy menstrual bleeding, or more bleeding than expected after surgery. These are the same symptoms that prompt a hemostasis workup in primary care, where fibrinogen is measured alongside other clotting tests rather than interpreted alone[4].
Common causes. Reduced synthesis in significant liver disease is one. Consumption is another, as happens in disseminated intravascular coagulation, which can complicate solid tumours and other serious illness[9]. Major trauma with bleeding and large-volume resuscitation drops fibrinogen quickly through a mix of loss, dilution and consumption[3], and severe obstetric haemorrhage follows a similar pattern[7]. Inherited afibrinogenaemia, hypofibrinogenaemia and dysfibrinogenaemia are uncommon but real, and are identified through specialist testing that compares activity with antigen levels[2]. Some medications are associated with falling fibrinogen, including thrombolytic drugs and the antibiotic tigecycline, where coagulopathy has been reported in the literature[10]. Large venous malformations can also consume clotting factors locally, a feature described in blue rubber bleb naevus syndrome[11].
Long-term health impact. A mildly low value in an otherwise well person often reflects assay variation or a sample issue and settles on a repeat. A genuinely low result matters most around bleeding risk, so it is relevant before surgery, during pregnancy, and alongside any history of unusual bleeding. A low fibrinogen activity result with bleeding symptoms is worth discussing with a clinician promptly rather than watching and waiting.
Several things move this marker that have nothing to do with long-term health, which is why one reading is rarely the final word.
Testing conditions. Fibrinogen activity is run on citrated plasma, and the result is sensitive to how the sample is collected and handled. An underfilled tube changes the blood-to-citrate ratio, haemolysis and delayed processing affect the assay, and very high or very low haematocrit can bias the plasma volume. Certain anticoagulant drugs interfere directly with thrombin-based clotting assays and can make a Clauss result read falsely low, as can very high levels of fibrin degradation products, which is one reason method choice and assay limitations are actively discussed in the diagnostic literature[1].
Recent physiology. An infection, a vaccination reaction, a dental procedure, a hard training block, surgery or an injury in the preceding weeks can all raise an acute-phase protein. Pregnancy raises it by design[7]. Age and inherited variation set a baseline that lifestyle then shifts around[5].
Habits. Smoking is consistently associated with higher fibrinogen, and levels may fall after cessation. Regular aerobic activity and lower visceral fat are associated with lower concentrations. Dietary research has looked at several compounds for effects on clotting and vascular risk factors, including garlic, where reviews describe effects on multiple cardiovascular risk pathways while noting variable study quality[12]. Treat all of this as association rather than a lever that reliably moves one number.
Medications. Oestrogen-containing therapies, thrombolytics, some antibiotics[10] and several other prescription drugs are associated with shifts in fibrinogen. No dose, schedule or change to any medication belongs in an article. A licensed provider evaluates whether a prescription treatment is appropriate, and whether a medication you already take explains a result.
If you want the cleanest reading, test when you are well, not within a couple of weeks of an infection or a procedure, and keep the conditions similar each time you retest.
FitScript measures fibrinogen activity as part of its clotting and inflammation testing, within a membership that covers 150+ biomarkers tested per year.
The value of running it inside a broad panel is context. A fibrinogen result on its own tells you little, but read next to inflammatory markers, liver values, platelet count and metabolic markers, the pattern usually points somewhere. Atlas, FitScript's AI health advisor, interprets the result against your other markers and your history, and writes that interpretation into your FitScript, the personalized output generated from your biology. Repeat testing then shows whether a raised value was a passing acute-phase response or a persistent signal, which is the question that actually matters.
Where a result suggests something beyond lifestyle and nutrition, a licensed provider reviews the member and evaluates whether any treatment is appropriate. Nothing on this page replaces that evaluation, and an abnormal result should never be ignored.
Fibrinogen is most informative when read beside the other markers that share its biology, because they separate inflammation from clotting.
| Marker | Why it is worth reading alongside |
|---|---|
| C-Reactive Protein | Another liver-made acute-phase protein that rises and falls faster, helping date an inflammatory episode |
| ESR | Driven substantially by fibrinogen itself, so the two often move together |
| Interleukin-6 | An upstream cytokine signal that drives hepatic acute-phase production |
| TNF-alpha | A second inflammatory cytokine that helps characterise the inflammatory pattern |
| Platelets | Fibrinogen bridges activated platelets, so count and function matter for both bleeding and clotting questions |
| Homocysteine | A separate vascular marker associated with endothelial function and cardiovascular risk |
Several of these markers are grouped together in FitScript's Advanced Inflammation testing, which is the usual way fibrinogen gets interpreted in context rather than in isolation.
Fibrinogen activity measures working clotting protein, reported in mg/dL and typically run by the Clauss method. Typical lab ranges sit near 200 to 400 mg/dL, and FitScript's optimal range is 200 to 300 mg/dL. High results most often reflect inflammation, smoking, body composition, pregnancy or an inherited baseline. Low results point towards reduced liver production, consumption or a structurally abnormal protein, and matter most for bleeding risk. Retest when you are well, read the marker beside CRP, ESR and platelets, and watch the trend. This article is educational and is not medical advice. Discuss your results, and any treatment, with a clinician or licensed provider who can see your full picture.
It measures how much of your fibrinogen is functionally able to form a clot, reported as a concentration in mg/dL. Most labs use the Clauss method, which adds excess thrombin to diluted plasma and converts the clotting time into a concentration using a calibration curve.
Not exactly. An activity assay measures working fibrinogen, while an antigen assay counts the protein whether or not it functions normally. Most routine reports are activity results. A clear gap between the two can suggest a structurally abnormal protein, which a clinician investigates with further specialist testing.
Typical adult laboratory reference ranges sit around 200 to 400 mg/dL, and FitScript's optimal range is 200 to 300 mg/dL. Ranges vary by lab, assay, age and sex, so compare your number with the range printed on your own report. FitScript's optimal range is a tracking target, not a diagnostic cut-off.
No. A single raised value does not diagnose anything. High fibrinogen most often reflects an acute-phase response to infection, injury or surgery, or ongoing drivers such as smoking, excess visceral fat, pregnancy or oestrogen-containing medication. A persistent elevation is worth discussing with a clinician who can look for the cause.
Sample issues are common culprits, including an underfilled citrate tube, haemolysis, delayed processing or an unusual haematocrit. Repeating the test under clean conditions usually clarifies it.
Fibrinogen activity itself is not a fasting-dependent marker, but it is usually drawn with other tests that may require fasting, so follow the instructions given with your draw. More important is timing. Testing while well, rather than within a couple of weeks of infection or surgery, gives a cleaner reading.
Regular aerobic activity and lower visceral fat are associated with lower fibrinogen concentrations, and levels may fall after smoking cessation. These are associations across populations rather than guarantees for one person, and a hard training session shortly before a draw can temporarily raise inflammatory markers instead.
That depends on why it was measured and what else is going on, so a clinician should set the interval. In general, a value outside the expected range after an illness is commonly rechecked once you have recovered, and ongoing tracking is done at the same cadence as the rest of your inflammation markers.